← All indications
Coronavirus Infections
Virus diseases caused by the CORONAVIRUS genus. Some specifics include transmissible enteritis of turkeys (ENTERITIS, TRANSMISSIBLE, OF TURKEYS); FELINE INFECTIOUS PERITONITIS; and transmissible gastroenteritis of swine (GASTROENTERITIS, TRANSMISSIBLE, OF SWINE).
Subtype terms (5)
More specific conditions that are subtypes of Coronavirus Infections in the MeSH hierarchy.
- COVID-19
1232 drugs (383 approved, 849 experimental)
- Enteritis, Transmissible, of Turkeys
- Feline Infectious Peritonitis
- Gastroenteritis, Transmissible, of Swine
- Severe Acute Respiratory Syndrome
158 drugs (76 approved, 82 experimental)
Drugs by status
Phase 4 trials (29)
- methylprednisolone
- acetylcysteine
- umifenovir
- bacille calmette-guerin
- hydroxychloroquine
- ritonavir
- insulin human
- nitazoxanide
- vitamin c
- oseltamivir
- linagliptin
- pneumococcal 13-valent conjugate vaccine
- lopinavir
- enoxaparin
- rivaroxaban
- budesonide
- chloroquine
- pioglitazone
- sodium bicarbonate
- unfractionated heparin
- dexamethasone
- baloxavir marboxil
- zinc sulfate
- mrna-1273
- bnt162b2
- coronavac
- tixagevimab
- cilgavimab
- regdanvimab
Phase 3 trials (53)
- melatonin
- vitamin e
- apn01
- artemisinin
- canakinumab
- folic acid
- imatinib
- remdesivir
- tenofovir
- baricitinib
- cobalamin
- ivermectin
- tradipitant
- nigella sativa
- atazanavir
- colchicine
- nicotine
- lidocaine
- honey
- fostamatinib
- sarilumab
- bevacizumab
- emtricitabine
- angiotensin 1-7
- tocilizumab
- spironolactone
- boswellia serrata
- curcumin
- azithromycin
- chlorpheniramine
- +23 more
Phase 2 trials (78)
- simvastatin
- sodium fluoride (18F)
- sodium citrate
- vitamin d3
- ciclesonide
- arformoterol
- aminolevulinic acid
- oxytocin
- captopril
- cetylpyridinium chloride
- ketamine
- coconut oil
- conestat alfa
- doxycycline
- selinexor
- ebselen
- essential oils
- enzalutamide
- fluvoxamine
- ethanol
- glycerin
- naltrexone
- chlorine dioxide
- bone marrow derived mesenchymal stem cells
- nitrogen
- ozone
- artesunate
- iodine
- nitric oxide
- fondaparinux sodium
- +48 more
Phase 1 trials (22)
- bicalutamide
- advax
- ino-9112
- varicella zoster virus glycoprotein e antigen
- diosmetine
- hesperidin
- mva-mers-s
- chadox1 mers
- regn3051
- regn3048
- dnl747
- eft226
- mva-mers-s_df1
- liberase
- allogeneic mesenchymal stem cells
- covid-19 specific t cell derived exosomes
- tak-671
- sir1-365
- human ezrin peptide
- covid19 recombinant spike protein
- vbi-2901a
- cx2101a
Organizations
Organization Involved with Phase 4 Indications (55)
- No.2 People's Hospital of Fuyang City
- University of Miami
- Hospital Materno-Perinatal "Mónica Pretelini Sáenz"
- Samaritan Health Services
- University of Texas at Houston
- E-MO Biology
- Nanyang Central Hospital
- Cedars-Sinai Medical Center
- Hospital Sirio-Libanes
- West Virginia University
- Taoyuan General Hospital
- Center for Drug Evaluation, Taiwan
- Oslo Metropolitan University
- Materno-Perinatal Hospital of the State of Mexico
- Clinica San Camilo, Argentina
- Wuhan University
- Henan Provincal People's Hospital
- Baylor University
- Government of Pakistan
- Chongqing Medical University
- Texas A&M University
- Hospital do Coracao
- Capital Medical University
- Hellenic Institute for the Study of Sepsis
- St. Francis Hospital, New York
- Saint Francis Hospital and Medical Center
- Albert Einstein Israelite Hospital
- Bengbu Medical College
- Brazilian Research In Intensive Care Network
- University of Barcelona
- +25 more
Organization Involved with Phase 3 Indications (227)
- Roche
- Sheikh Zayed Medical College
- Istituto Clinico Humanitas - Rozzano (MI), Italy
- PTC Therapeutics
- Saw Swee Hock School of Public Health
- Farhat Hached Hospital, Tunisia
- University of Vermont
- ESIC Medical College and Hospital Faridabad
- City polyclinic No. 4 of the UZO of Almaty
- University of Alberta
- Fundación Universitaria Autónoma de Las Américas
- Centro di Riferimento Oncologico - Aviano
- Tel Aviv University
- Indian Council of Medical Research
- Kigali Central University Hospital, Rwanda
- Swiss National Science Foundation
- Wilhelminenspital der Stadt Wien
- Dacima Consulting
- Assistance Publique - Hôpitaux de Paris
- Regeneron
- Institut National de la Santé Et de la Recherche Médicale, France
- Hamad Medical Corporation
- Nizam's Institute of Medical Sciences, Hyderabad, India
- Novartis
- COVAXX
- AO GENERIUM
- National Institute for Health Research, United Kingdom
- The International Network for Strategic Initiatives in Global HIV Trials
- Equillium
- Government of Jordan
- +197 more
Organization Involved with Phase 2 Indications (212)
- Chronic Obstructive Pulmonary Disease Trial Network, Denmark
- Government of Canada
- Apellis Pharmaceuticals, Inc.
- Case Western Reserve University
- Government of Nova Scotia
- Dynamic Solutions
- Pharmamel S.L.
- Umea University
- University of Sorocaba
- University of Gothenburg
- Hospital Naval Marcilio Dias
- Dalhousie University
- Verona Pharma plc
- Sundsvall Hospital
- Abu Dhabi Stem Cells Center
- GlaxoSmithKline
- GeneOne Life Science
- SynaVir
- Medical Research Council, South Africa
- Altimmune, Inc.
- Fujian Medical University
- Hospital Central da Aeronáutica, Rio de Janeiro
- Relief Therapeutics
- Hospital Estadual de Doenças Tropicais Dr Anuar Auad
- American British Cowdray Medical Center
- Siberian State Medical University
- Northwestern University
- Mater Dei Hospital, Brazil
- TriHealth
- Hospital de Força Aérea de São Paulo
- +182 more
Organization Involved with Phase 1 Indications (51)
- Ascension Health
- Pulmoquine Therapeutics, Inc
- SingHealth Investigational Medicine Unit
- Ludwig Maximilians University
- Xinxiang Medical University
- IDT Biologika
- National Guard Health Affairs
- Linear Clinical Research
- Effector Therapeutics
- Shahid Beheshti University of Medical Sciences
- International Brain Research Foundation
- Healeon Medical Inc
- Stanford University
- Wuhan Jinyintan Hospital, Wuhan, China
- CTC Bio, Inc.
- University of Chicago
- Eijkman Institute for Molecular Biology, Jakarta, Indonesia
- Ridgeback Biotherapeutics, LP
- Oklahoma Medical Research Foundation
- Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
- Cellular Biomedicine Group Ltd.
- Sironax USA, Inc.
- Akeso Pharmaceuticals, Inc.
- University of California, Los Angeles
- Daewoong Pharmaceutical Co. LTD.
- Government of Saudi Arabia
- CR2O
- Central Adelaide Local Health Network Incorporated
- Xinjiang Medical University
- Osaka University
- +21 more
Organization Involved with Other Experimental Indications (38)
- University of Nottingham
- WanBangDe Pharmaceutical Group Co.,Ltd.
- Liverpool John Moores University
- Corpometria Institute
- Instituto Nacional de Enfermedades Respiratorias
- Hudson Medical
- Ascletis Pharmaceuticals Co., Ltd.
- University of Brescia
- Química Luar SRL
- Beximco
- Mesoblast, Inc.
- Cantonal Hosptal, Baselland
- Tasly Pharmaceuticals, Inc.
- University of Massachusetts
- Bioithas SL
- Applied Biology, Inc.
- Hospital de Clínicas "Jose de San Martin"
- University of Health Sciences Lahore
- Zhejiang University
- Aferetica
- Qingfeng Pharmaceutical Group
- The Cleveland Clinic
- Wenzhou Medical University
- Ospedale di Bergamo
- Centro de Excelencia en Productos y Procesos Córdoba
- Lancaster General Hospital
- University of Nice Sophia Antipolis
- United States Army
- National Council of Scientific and Technical Research, Argentina
- Wuhan Hamilton Bio-technology Co., Ltd
- +8 more